{
    "organizations": [],
    "uuid": "4cc99659f60d83e47432c216edaf8aaf3541896a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-la-jolla-pharmaceutical-says-estab/brief-la-jolla-pharmaceutical-says-established-wholesale-acquisition-cost-of-single-dose-vial-of-giapreza-at-1500-vial-idUSFWN1PP0SE",
    "ord_in_thread": 0,
    "title": "BRIEF-La Jolla Pharmaceutical Says Established Wholesale Acquisition Cost of Single-Dose Vial Of Giapreza At $1,500/ Vial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 22 AM / Updated 12 minutes ago BRIEF-La Jolla Pharmaceutical Says Established Wholesale Acquisition Cost of Single-Dose Vial Of Giapreza At $1,500/ Vial Reuters Staff 1 Min Read \nJan 30 (Reuters) - La Jolla Pharmaceutical Co: \n* LA JOLLA PHARMACEUTICAL CO - ESTABLISHED WHOLESALE ACQUISITION COST OF $1,500 PER VIAL FOR A 1 ML, SINGLE-DOSE, 2.5 MG/ML VIAL OF GIAPREZA Source text: ( bit.ly/2nm3hfv ) Further company coverage:",
    "published": "2018-01-30T19:22:00.000+02:00",
    "crawled": "2018-01-30T13:38:14.024+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "jolla",
        "pharmaceutical",
        "say",
        "established",
        "wholesale",
        "acquisition",
        "cost",
        "vial",
        "giapreza",
        "vial",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "la",
        "jolla",
        "pharmaceutical",
        "co",
        "la",
        "jolla",
        "pharmaceutical",
        "co",
        "established",
        "wholesale",
        "acquisition",
        "cost",
        "per",
        "vial",
        "ml",
        "vial",
        "giapreza",
        "source",
        "text",
        "company",
        "coverage"
    ]
}